MAP2K6 and non-small cell lung carcinoma: Our results showed that the expression level of MAP2K6 was significantly upregulated in NSCLC tissues, and MAP2K6 knockdown inhibited the growth of xenografts by significantly inhibiting the proliferation of NSCLC cells.